158 related articles for article (PubMed ID: 10361107)
21. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
[TBL] [Abstract][Full Text] [Related]
22. Long-term renal function following bone marrow transplantation.
Grönroos MH; Bolme P; Winiarski J; Berg UB
Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
[TBL] [Abstract][Full Text] [Related]
23. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation.
Thomas BC; Stanhope R; Plowman PN; Leiper AD
Eur J Pediatr; 1993 Nov; 152(11):888-92. PubMed ID: 8276017
[TBL] [Abstract][Full Text] [Related]
24. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation.
Wingard JR; Plotnick LP; Freemer CS; Zahurak M; Piantadosi S; Miller DF; Vriesendorp HM; Yeager AM; Santos GW
Blood; 1992 Feb; 79(4):1068-73. PubMed ID: 1737091
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study.
Blume KG; Kopecky KJ; Henslee-Downey JP; Forman SJ; Stiff PJ; LeMaistre CF; Appelbaum FR
Blood; 1993 Apr; 81(8):2187-93. PubMed ID: 8471778
[TBL] [Abstract][Full Text] [Related]
26. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
[TBL] [Abstract][Full Text] [Related]
27. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
Locasciulli A; Oneto R; Bacigalupo A; Socié G; Korthof E; Bekassy A; Schrezenmeier H; Passweg J; Führer M;
Haematologica; 2007 Jan; 92(1):11-8. PubMed ID: 17229630
[TBL] [Abstract][Full Text] [Related]
28. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma.
Nysom K; Holm K; Michaelsen KF; Hertz H; Jacobsen N; Müller J; Mølgaard C
Bone Marrow Transplant; 2000 Jan; 25(2):191-6. PubMed ID: 10673679
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM).
Devergie A; Blaise D; Attal M; Tigaud JD; Jouet JP; Vernant JP; Bordigoni P; Ifrah N; Dauriac C; Cahn JY
Blood; 1995 Apr; 85(8):2263-8. PubMed ID: 7718899
[TBL] [Abstract][Full Text] [Related]
30. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
[TBL] [Abstract][Full Text] [Related]
31. Gonadal function after bone marrow transplantation for acute leukemia during childhood.
Sarafoglou K; Boulad F; Gillio A; Sklar C
J Pediatr; 1997 Feb; 130(2):210-6. PubMed ID: 9042122
[TBL] [Abstract][Full Text] [Related]
32. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Deeg HJ; Socié G; Schoch G; Henry-Amar M; Witherspoon RP; Devergie A; Sullivan KM; Gluckman E; Storb R
Blood; 1996 Jan; 87(1):386-92. PubMed ID: 8547667
[TBL] [Abstract][Full Text] [Related]
33. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning.
Shankar SM; Bunin NJ; Moshang T
J Pediatr Hematol Oncol; 1996 Nov; 18(4):362-6. PubMed ID: 8888742
[TBL] [Abstract][Full Text] [Related]
34. The development of cataract in children as a late side-effect of bone marrow transplantation.
Calissendorff B; Bolme P; el Azazi M
Bone Marrow Transplant; 1991 Jun; 7(6):427-9. PubMed ID: 1873589
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychological deficits in very young bone marrow transplant recipients.
Smedler AC; Bolme P
Acta Paediatr; 1995 Apr; 84(4):429-33. PubMed ID: 7540899
[TBL] [Abstract][Full Text] [Related]
36. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation.
Brauner R; Adan L; Souberbielle JC; Esperou H; Michon J; Devergie A; Gluckman E; Zucker JM
J Pediatr; 1997 May; 130(5):785-92. PubMed ID: 9152289
[TBL] [Abstract][Full Text] [Related]
37. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Blood; 1998 Feb; 91(3):756-63. PubMed ID: 9446633
[TBL] [Abstract][Full Text] [Related]
38. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
39. Changes in height, weight and plasma leptin after bone marrow transplantation.
Couto-Silva AC; Trivin C; Esperou H; Michon J; Fischer A; Brauner R
Bone Marrow Transplant; 2000 Dec; 26(11):1205-10. PubMed ID: 11149732
[TBL] [Abstract][Full Text] [Related]
40. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
